Udenyca Copay Assistance

Cómo funciona la asistencia

Optimizando la experiencia de farmacia especializada de nuestros pacientes con una comodidad de servicio completo sin igual

1. Verifique su cobertura/verificación de beneficios

Nuestro equipo de facturadores expertos encuentra las mejores vías de cobertura que minimizan los costos de bolsillo.
2. Transferir receta a AmeriPharma®

Procesamos su receta trabajando con su farmacia o prescriptor anterior, haciendo que la transición sea rápida y sencilla.
3. Autorización previa

Nuestro equipo de especialistas obtiene la aprobación de sus compañías de seguros en un plazo de 24 a 72 horas.
4. Asistencia para copagos y ayuda financiera

Garantizamos ayuda financiera y reducimos copagos, gastos de bolsillo y deducibles elevados. Hasta la fecha, AmeriPharma® Specialty Care ha obtenido $55 millones en asistencia financiera para nuestros pacientes.
5. Coordinación de atención de enfermería si es necesario

AmeriPharma® prioriza su agenda y su entorno hogareño al programar y coordinar una de nuestras enfermeras especializadas para sus infusiones en el hogar.
6. Coordinación de entrega

Los medicamentos se entregan siempre en estricto cumplimiento de los requisitos específicos de envío. Las entregas con cadena de frío al día siguiente y al día siguiente se coordinan según su horario.

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/pharmacist.jpg

What Is Udenyca?

Udenyca is a biosimilar (similar in molecular structure and function) of pegfilgrastim.

Pegfilgrastim is a medication that supports the growing process of stem cells in the bone marrow and aids patients who undergo chemotherapy in replenishing their white blood cell count. Pegfilgrastim contains a PEG (polyethylene glycol) component compared to filgrastim. This allows this medication to stay in the body longer, which leads to less dosing frequency.

Udenyca is a man-made product that mimics a substance in our bodies. It helps stimulate the growth of neutrophils in the human body, which plays a big role in protecting the patient against infections.

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/block_image_1.jpg

What is Udenyca Used For?

Udenyca is a biosimilar injection. Biosimilars are FDA-approved medications that are made to be as safe and effective as the original biologics. There are no clinically meaningful differences between a biosimilar and the original medication.

Udenyca is an FDA-approved medication that is administered after chemotherapy to help reduce the incidence of infections. Patients with non-myeloid malignancies who receive myelosuppressive anti-cancer medications are usually susceptible to an increased risk for febrile (showing fever) neutropenia (lower than normal neutrophil count). This decreases the patient’s ability to fight off infection and puts a patient at greater risk of getting one. Neutrophils are a type of white blood cell that helps in fighting an infection and Udenyca can play a role in repleting one’s neutrophil count.

Copago y asistencia financiera

La farmacia especializada AmeriPharma™ alivia las cargas financieras de los pacientes y sus familias

Un software avanzado localiza fuentes de financiación para conectarlo con programas de fundaciones de alto valor
Uno de nuestros especialistas en asistencia de copagos le ayudará con el proceso de solicitud.
Se le enviarán a usted y a su médico actualizaciones automáticas sobre el estado de la financiación.

https://ameripharmaspecialty.com/wp-content/uploads/2024/05/doctor-patient.jpg

Udenyca Administration Information

Udenyca comes in a 6 mg/0.6 ml prefilled syringe. Udenyca is administered subcutaneously, into the fatty layer between the muscle and the skin. It is administered once per chemotherapy cycle after the completion of the chemotherapy regimen. For pediatric patients weighing less than 10 kg, administer 0.1 mg/kg of Udenyca. Administration of less than 0.6 ml is not recommended as it may potentially lead to dosing errors.

Do not administer Udenyca between 14 days before or 24 hours after the administration of cytotoxic chemotherapy.

The carton should be removed from the fridge and left to sit at room temperature for a minimum of 30 minutes prior to injection. Discard any prefilled syringe if left at room temperature for 48 hours or more.

Do not administer Udenyca if there is any discoloration or particulate matter detected in the prefilled syringe.

Avoid use of heat sources (such as tanning beds, heating pads, electric blankets, saunas, and hot tubs). Avoid long, hot baths or sunbathing. Excessive heat may cause your body temperature to rise, potentially causing accelerated metabolism of the drug.

Do not travel, drive, or do other tasks or actions that require alertness during hours 26 through 29 after the injection.

Udenyca Side Effects

Serious side effects include:

Spleen rupture – enlargement of the spleen may lead to spleen rupture which can cause pain in the left upper stomach area
Acute respiratory distress syndrome (ARDs) – fluid leakage in the lungs that can lead to serious lung problems such as:
- Shortness of breath with or without fever
- Trouble breathing
- Fast rate of breathing
Myelodysplastic syndrome and acute myeloid leukemia – Udenyca may increase the risk of blood cancer in patients who have breast or lung cancer
Leukocytosis (increased white blood cell count)
Glomerulonephritis (kidney injury)
Swelling in the face or ankle
Blood in the urine
Severe allergic reactions (anaphylaxis) such as:
- Full body rash
- Shortness of breath
- Aumento de la frecuencia cardíaca
- Sweating
- Mareo
Sickle cell crisis – Using Udenyca in patients with sickle cell anemia may lead to death

Common side effects include:

Bone pain
Pain in the legs and arms

Seguros aceptados

Aceptamos Medicare, Medicaid multiestatal, Medi-Cal, Blue Shield y la mayoría de los seguros privados. Llámenos para obtener más información sobre su cobertura.